Minaris Advanced Therapies dans l'actualité
Thérapie génique cellulaire mondiale
Tamtam a trouvé 20 articles récents sur Minaris Advanced Therapies.
- Bionova Scientific and Minaris Announce Partnership to Accelerate Plasmid DNA Supply for Cell and Gene Therapy Manufacturing | Newswise
- Building Commercial Readiness in Advanced Therapies
- Minaris Expands Its Apprentice.io Partnership, Bringing Digital Manufacturing to Its Philadelphia Headquarters
- Minaris Enhances GMP Cell Banking Capabilities at Philadelphia Facility
- Minaris Enhances GMP Cell Banking Suites at Philadelphia Facility
- Minaris Fortifies Philly Hub to Streamline Cell & Gene Therapy Production
- Minaris Enhances GMP Cell Banking Suites at Philadelphia Facility
- Minaris Expands Rapid Mycoplasma Detection Services with bioMérieux's BIOFIRE® Platform to Reduce Turnaround Time for Release and In-Process Testing
- Minaris Expands Rapid Mycoplasma Testing Capabilities to Accelerate Cell and Gene Therapy Manufacturing
- Minaris Expands Rapid Mycoplasma Detection Services with bioMérieux's BIOFIRE® Platform to Reduce Turnaround Time for Release and In-Process Testing
- Minaris Adds BIOFIRE for Faster Mycoplasma Detection
- Aldevron and Minaris Renew Lentiviral Plasmid Agreement to Accelerate Gene-Modified Cell Therapy Development
- Aldevron and Minaris Renew Lentiviral Plasmid Agreement to Accelerate Cell and Gene Therapy Development
- Aldevron and Minaris Renew Lentiviral Plasmid Agreement to Accelerate Gene-Modified Cell Therapy Development
- Aldevron and Minaris Renew Lentiviral Plasmid Agreement to Accelerate Gene-Modified Cell Therapy Development
- Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program
- Minaris Delivers 100% Manufacturing and Release Success for Chim
- Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program
- Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program
- Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program
Articles collectés par Tamtam et retenus lorsqu'ils portent sur l'entreprise, des plus récents aux plus anciens. Chacun renvoie à sa source.
Vous vendez à des entreprises comme Minaris Advanced Therapies ?
Tamtam trouve les entreprises qui correspondent à votre client idéal, analyse chaque compte et vous dit qui contacter, et quand.
Trouver des entreprises similaires